Identification and validation of dysregulated metabolic pathways in metastatic renal cell carcinoma (Q38484441)

3 September 2017

Identification and validation of dysregulated metabolic pathways in metastatic renal cell carcinoma (English)

1 reference

3 September 2017

Nicole M A White

1

1 reference

3 September 2017

Daniel W Newsted

2

1 reference

3 September 2017

Olena Masui

3

1 reference

3 September 2017

Alexander D Romaschin

4

1 reference

3 September 2017

K W Michael Siu

5

1 reference

3 September 2017

George M Yousef

6

1 reference

3 September 2017

19 October 2013

1 reference

3 September 2017

1 reference

3 September 2017

35

1 reference

3 September 2017

3

1 reference

3 September 2017

1833-1846

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-013-1245-6

3 September 2017

0 references

cites work

State of the science: an update on renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

Treatment of metastatic renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

Treatment selection in metastatic renal cell carcinoma: expert consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

Sunitinib in patients with metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

From bench to bedside: current and future applications of molecular profiling in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

Multilevel whole-genome analysis reveals candidate biomarkers in clear cell renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

Renal cell carcinoma: where will the state-of-the-art lead us?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

Potential tumor markers of renal cell carcinoma: α-enolase for postoperative follow up, and galectin-1 and galectin-3 for primary detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

Differential protein expressions in renal cell carcinoma: new biomarker discovery by mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

Understanding and managing renal cell carcinoma: can proteomic studies contribute to clinical practice?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

Exploring the pathogenesis of renal cell carcinoma: pathway and bioinformatics analysis of dysregulated genes and proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

Personalized medicine: marking a new epoch in cancer patient management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

Quantitative proteomic analysis in metastatic renal cell carcinoma reveals a unique set of proteins with potential prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

KEGG for integration and interpretation of large-scale molecular data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

Evidence for gains at 15q and 20q in brain metastases of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

Chromosomal alterations in the clonal evolution to the metastatic stage of squamous cell carcinomas of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

-8p12-23 and +20q are predictors of subtypes and metastatic pathways in colorectal cancer: construction of tree models using comparative genomic hybridization data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

Analysis of colorectal tumor progression by microdissection and comparative genomic hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

Incidence of chromosomal imbalances in advanced colorectal carcinomas and their metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

Loss of Dpc4 expression in colonic adenocarcinomas correlates with the presence of metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

Frequent LOH on 22q12.3 and TIMP-3 inactivation occur in the progression to secondary glioblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

Chromosomal imbalances of primary and metastatic lung adenocarcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

Exploring the role of miRNAs in renal cell carcinoma progression and metastasis through bioinformatic and experimental analyses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

Convergent multi-miRNA targeting of ApoE drives LRP1/LRP8-dependent melanoma metastasis and angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

Mitochondrial proteomics analysis of tumorigenic and metastatic breast cancer markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

Two-dimensional electrophoretic comparison of metastatic and non-metastatic human breast tumors using in vitro cultured epithelial cells derived from the cancer tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

Prognostic significance of drug-regulated genes in high-grade osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

Overexpression of the thymosin beta-4 gene is associated with malignant progression of SW480 colon cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

Elevated expression of thymosin β4, vascular endothelial growth factor (VEGF), and hypoxia inducible factor (HIF)-1α in early-stage cervical cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

Molecular profiling of cervical cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

Identification of potential biomarkers for giant cell tumor of bone using comparative proteomics analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

THE METABOLISM OF TUMORS IN THE BODY

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

The genetic basis of kidney cancer: a metabolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

A genetically encoded FRET lactate sensor and its use to detect the Warburg effect in single cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

Reversing the Warburg effect as a treatment for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

Why do cancers have high aerobic glycolysis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

Glufosfamide as a new oxazaphosphorine anticancer agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

A Phase 1 dose-escalation trial of glufosfamide in combination with gemcitabine in solid tumors including pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

A randomised Phase III trial of glufosfamide compared with best supportive care in metastatic pancreatic adenocarcinoma previously treated with gemcitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

Phase I clinical and pharmacokinetic study of the glucose-conjugated cytotoxic agent D-19575 (glufosfamide) in patients with solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

Targeting GLUT1 and the Warburg effect in renal cell carcinoma by chemical synthetic lethality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

Targeted cancer therapy with a 2-deoxyglucose-based adriamycin complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

The TCA cycle and tumorigenesis: the examples of fumarate hydratase and succinate dehydrogenase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

Metabolite profiling of human colon carcinoma--deregulation of TCA cycle and amino acid turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

Respiratory metabolism: glycolysis, the TCA cycle and mitochondrial electron transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

Gain of chromosome arm 1q in atypical meningioma correlates with shorter progression-free survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

Copy number gain of 1q25 predicts poor progression-free survival for pediatric intracranial ependymomas and enables patient risk stratification: a prospective European clinical trial cohort analysis on behalf of the Children's Cancer Leukaemia Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

Genome-wide profiling of chromosomal alterations in renal cell carcinoma using high-density single nucleotide polymorphism arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

Gene expression profiles of progressive pancreatic endocrine tumours and their liver metastases reveal potential novel markers and therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

Analysis of candidate genes through a proteomics-based approach in primary cell lines from malignant melanomas and their metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

Proteome analysis of human pancreatic cancer cell lines with highly liver metastatic potential by antibody microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

Proteomics analysis of differentially expressed metastasis-associated proteins in adenoid cystic carcinoma cell lines of human salivary gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

The proteins FABP7 and OATP2 are associated with the basal phenotype and patient outcome in human breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

FABP7 expression in glioblastomas: relation to prognosis, invasion and EGFR status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

Comparative proteomic approach identifies PKM2 and cofilin-1 as potential diagnostic, prognostic and therapeutic targets for pulmonary adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

Analysis for the combination expression of CK20, FABP1 and MUC2 is sensitive for the prediction of peritoneal recurrence in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

Genomic aberrations in squamous cell lung carcinoma related to lymph node or distant metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1245-6

Warburg effect associated with transformed lymphoplasmacytic lymphoma to diffuse large B-cell lymphoma.

21 January 2018

1 reference

12 December 2020

Comparison of DNA gains and losses in primary renal clear cell carcinomas and metastatic sites: importance of 1q and 3p copy number changes in metastatic events

1 reference

12 December 2020

Chromosomal alterations during metastasis formation of head and neck squamous cell carcinoma.

1 reference

12 December 2020

AMPK can suppress tumorigenesis and the Warburg effect

1 reference

12 December 2020

Deletions of chromosome 1p and 15q are associated with aggressiveness of gastrointestinal stromal tumors

1 reference

12 December 2020

Chromosomal markers associated with metastasis in two colon cancer cell lines established from the same patient

1 reference

12 December 2020

Elevated expression of SerpinA1 and SerpinA3 in HLA-positive cervical carcinoma

1 reference

12 December 2020

Association of Vimentin overexpression and hepatocellular carcinoma metastasis

1 reference

12 December 2020

Quantitative Proteomic and Genomic Profiling Reveals Metastasis-Related Protein Expression Patterns in Gastric Cancer Cells

1 reference

12 December 2020

Personalized cancer genomics: the road map to clinical implementation

1 reference

12 December 2020

Identification of potential prognostic biomarkers for node-negative breast tumours by proteomic analysis: a multicentric 2004 national PHRC study

1 reference

12 December 2020

High expression of S100A11 in pancreatic adenocarcinoma is an unfavorable prognostic marker

1 reference

12 December 2020

Proteomic identification of PKM2 and HSPA5 as potential biomarkers for predicting high-risk endometrial carcinoma

1 reference

12 December 2020

Nutrient deprivation induces the Warburg effect through ROS/AMPK-dependent activation of pyruvate dehydrogenase kinase.

1 reference

12 December 2020

Chromosomal genotype in breast cancer progression: comparison of primary and secondary manifestations.

1 reference

12 December 2020

The S100 proteins for screening and prognostic grading of bladder cancer

1 reference

12 December 2020

Translating molecular signatures of renal cell carcinoma into clinical practice

1 reference

12 December 2020

Comparative genomic hybridization analysis of genetic aberrations associated with development and progression of biliary tract carcinomas

1 reference

12 December 2020

Glufosfamide: beta-D-Glc-IPM, D 19575

1 reference

12 December 2020

CGH pattern of esthesioneuroblastoma and their metastases

1 reference

12 December 2020

Significance of the small subtelomeric area of chromosome 1 (1p36.3) in the progression of malignant melanoma: FISH deletion screening with YAC DNA probes

1 reference

12 December 2020

High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers

1 reference

12 December 2020

Intratumoural cytogenetic heterogeneity of sporadic colorectal carcinomas suggests several pathways to liver metastasis

1 reference

12 December 2020

10.1007/S13277-013-1245-6

Identifiers

DOI

1 reference

Dimensions Publication ID

3 September 2017

0 references

1 reference